Last reviewed · How we verify

NCT05278000: PACIFI

Improving Adherence to Controller Medication in Children With Asthma

Completed Last updated 23 July 2025
What this trial tests

trial testing Presence of scarcity mindset in Asthma in Children in 201 participants. Completed in 18 July 2025.

Timeline
25 August 2022
Primary endpoint
12 July 2025
18 July 2025

Quick facts

Lead sponsorSt. Justine's Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment201
Start date25 August 2022
Primary completion12 July 2025
Estimated completion18 July 2025
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

St. Justine's Hospital

Who can join

Adults 2 to 17, any sex, with Asthma in Children or Adherence, Medication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Asthma is a common pediatric condition that can be well controlled with regular use of controller medications, however adherence to these is low, resulting in preventable exacerbations and important short- and long-term morbidity. This project's aim is to understand cognitive factors influencing adherence to medication among children with asthma, examining specifically the influence of scarcity (a mindset experienced by those with less than they need, which is cognitively taxing) and future discounting (the focus on present concerns at the expense of distant ones). Using a single-centre, 12-month, prospective observation cohort study of 300 families of children with asthma, the objectives of this study are to: 1. Identify the relationship between scarcity, future discounting, and adherence to asthma medication. 2. Evaluate whether unmet social needs are associated with scarcity and future discounting. 3. Determine whether scarcity and future discounting mediate the relationship between unmet social needs and adherence to medication. Primary outcome will be adherence to controller medication, which will be measured for the 12 months of follow-up on a scale of 0 to 100%, by the 'proportion of prescribed days covered (PPDC)', a validated index calculated as the number of days for which the drug was dispensed by a pharmacy, divided by the number of days for which it was prescribed. Other measures include screening families for unmet social needs, psychometric testing to document scarcity and future discounting. This study will increase our understanding of how cognitive factors influence adherence to asthma controller medication, which will be instrumental in developing targeted interventions to improve adherence, especially for families experiencing with unmet social needs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of Unmet Social Needs, Scarcity, and Future Discounting on Adherence to Treatment in Children With Asthma: Protocol for a Prospective Cohort Study.
    Drouin O, Perez T, Barnett TA, Ducharme FM, et al · · 2023 · cited 3× · PMID 36881458 · DOI 10.2196/37318

Verify or expand the search:

Other recruiting trials for Asthma in Children

Currently open trials in the same condition.

Other St. Justine's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05278000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing